This page has only limited features, please log in for full access.

Mrs. Marlena Paniczko
Department of Population Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Poland

Basic Info


Research Keywords & Expertise

0 Obesity prevention
0 fat mass
0 left ventricle
0 left ventricular mass index
0 diastolic dysfunction

Honors and Awards

The user has no records in this section


Career Timeline

The user has no records in this section.


Short Biography

The user biography is not available.
Following
Followers
Co Authors
The list of users this user is following is empty.
Following: 0 users

Feed

Journal article
Published: 20 August 2021 in Journal of Clinical Medicine
Reads 0
Downloads 0

Lipid-lowering in patients with coronary artery disease (CAD) is related to a lower risk of cardiovascular events. We evaluated factors related to the management of hypercholesterolemia in patients with established CAD. Patients were interviewed 6–18 months after hospitalization for an acute coronary syndrome (ACS) or a myocardial revascularization procedure. Statins were prescribed at discharge to 94.4% of patients, while 68.1% of the patients hospitalized for an ACS were prescribed a high-dose statin. Hospitalization in a teaching hospital, percutaneous coronary intervention, cholesterol measurement during hospitalization and the male sex were related to prescription of statins at discharge. The intensity of lipid-lowering therapy in the post-discharge period increased in 17.3%, decreased in 11.7%, and did not change in 71.0% of the patients. The prescription of a lipid-lowering drug (LLD) at discharge (odds ratio 5.88 [95% confidence intervals 3.05–11.34]) and a consultation with a cardiologist (2.48 [1.51–4.08]) were related to the use of LLDs, while age (1.32 [1.10–1.59] per 10 years), loneliness (0.42 [0.19–0.94]), professional activity (1.56 [1.13–2.16]), and diabetes (1.66 [1.27–2.16]) were related to achieving an LDL cholesterol goal 6–18 months after discharge. In conclusion, health-system-related factors are associated with the LLD utilization, whereas mainly patient-related factors are related to the control of hypercholesterolemia following hospitalization for CAD.

ACS Style

Piotr Jankowski; Paweł Kozieł; Małgorzata Setny; Marlena Paniczko; Maciej Haberka; Maciej Banach; Dirk De Bacquer; Guy De Backer; Kornelia Kotseva; David Wood; Zbigniew Gąsior; Karol Kamiński; Dariusz A. Kosior; Andrzej Pająk. Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey. Journal of Clinical Medicine 2021, 10, 3711 .

AMA Style

Piotr Jankowski, Paweł Kozieł, Małgorzata Setny, Marlena Paniczko, Maciej Haberka, Maciej Banach, Dirk De Bacquer, Guy De Backer, Kornelia Kotseva, David Wood, Zbigniew Gąsior, Karol Kamiński, Dariusz A. Kosior, Andrzej Pająk. Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey. Journal of Clinical Medicine. 2021; 10 (16):3711.

Chicago/Turabian Style

Piotr Jankowski; Paweł Kozieł; Małgorzata Setny; Marlena Paniczko; Maciej Haberka; Maciej Banach; Dirk De Bacquer; Guy De Backer; Kornelia Kotseva; David Wood; Zbigniew Gąsior; Karol Kamiński; Dariusz A. Kosior; Andrzej Pająk. 2021. "Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey." Journal of Clinical Medicine 10, no. 16: 3711.

Journal article
Published: 07 August 2021 in Vaccines
Reads 0
Downloads 0

Since the declaration of the SARS-CoV-2 pandemic confirmed by World Health Organization, work on the development of vaccines has been stimulated. When vaccines are commonly available, a major problem is persistent vaccine hesitancy in many European countries. The main goal of our study was to understand the multidimensional factors inducing this phenomenon in Poland. Our study was carried out at the third wave’s peak of the pandemic, with record rates of daily cases and deaths associated with COVID-19. The results indicate that vaccine hesitancy/acceptability should always be considered in an interdisciplinary manner and according to identified factors where most negative attitudes could be altered. Our analyses included the assessment of a representative quota sample of adult Poles (N = 1000). The vaccine hesitancy in the studied group reached 49.2%. We performed stepwise logistic regression modeling to analyze variables set into six trajectories (groups) predicting the willingness to vaccinate. Apart from typical, socio-demographic and economic determinants, we identified the fear of vaccines’ side effects, beliefs in conspiracy theories and physical fitness. We were also able to establish the order of importance of factors used in a full model of all impact trajectories.

ACS Style

Paweł Sowa; Łukasz Kiszkiel; Piotr Laskowski; Maciej Alimowski; Łukasz Szczerbiński; Marlena Paniczko; Anna Moniuszko-Malinowska; Karol Kamiński. COVID-19 Vaccine Hesitancy in Poland—Multifactorial Impact Trajectories. Vaccines 2021, 9, 876 .

AMA Style

Paweł Sowa, Łukasz Kiszkiel, Piotr Laskowski, Maciej Alimowski, Łukasz Szczerbiński, Marlena Paniczko, Anna Moniuszko-Malinowska, Karol Kamiński. COVID-19 Vaccine Hesitancy in Poland—Multifactorial Impact Trajectories. Vaccines. 2021; 9 (8):876.

Chicago/Turabian Style

Paweł Sowa; Łukasz Kiszkiel; Piotr Laskowski; Maciej Alimowski; Łukasz Szczerbiński; Marlena Paniczko; Anna Moniuszko-Malinowska; Karol Kamiński. 2021. "COVID-19 Vaccine Hesitancy in Poland—Multifactorial Impact Trajectories." Vaccines 9, no. 8: 876.

Journal article
Published: 05 May 2021 in Journal of Clinical Medicine
Reads 0
Downloads 0

Dysglycemia is a public health challenge for the coming decades, especially in patients with chronic coronary syndromes (CCS). We want to assess the prevalence of undiagnosed diabetes mellitus (DM) and prediabetes, as well as identify factors associated with the development of dysglycaemia in patients with CCS. In total, 1233 study participants (mean age 69 ± 9 years), who, between 6 and 18 months earlier were hospitalized for acute coronary syndrome or elective revascularization, were examined (71.4% men). The diagnosis of DM, impaired fasting glucose (IFG), impaired glucose tolerance (IGT) have been made according to World Health Organization (WHO) criteria. Based on the oral glucose tolerance test (OGTT) results, DM has been newly diagnosed in 28 (5.1%, mean age 69.9 ± 8.4 years) patients, 75% were male (n = 21). Prediabetes has been observed in 395 (72.3%) cases. IFG was found in 234 (42.9%) subjects, 161 (29.5%) individuals had IGT. According to multinomial logistic regression, body mass index (BMI) and high-density lipoprotein cholesterol (HDL-C) should be considered when assessing risk of development of dysglycaemia after discharge from the hospital. Among people with previously diagnosed DM, a significantly higher percentage were willing to change their lifestyles after the index event compared to other patients. Patients with chronic coronary syndromes suffer a very high frequency of dysglycaemia. Most patients with chronic coronary syndromes, especially those with high BMI or low HDL-C, should be considered for screening for dysglycemia using OGTT within the first year after hospitalization. A higher percentage of patients who were aware of their diabetic status changed their lifestyles, which added the benefit of timely diagnosis and treatment of diabetes.

ACS Style

Natalia Drobek; Paweł Sowa; Piotr Jankowski; Maciej Haberka; Zbigniew Gąsior; Dariusz Kosior; Danuta Czarnecka; Andrzej Pająk; Karolina Szostak-Janiak; Agnieszka Krzykwa; Małgorzata Setny; Paweł Kozieł; Marlena Paniczko; Jacek Jamiołkowski; Irina Kowalska; Karol Kamiński. Undiagnosed Diabetes and Prediabetes in Patients with Chronic Coronary Syndromes—An Alarming Public Health Issue. Journal of Clinical Medicine 2021, 10, 1981 .

AMA Style

Natalia Drobek, Paweł Sowa, Piotr Jankowski, Maciej Haberka, Zbigniew Gąsior, Dariusz Kosior, Danuta Czarnecka, Andrzej Pająk, Karolina Szostak-Janiak, Agnieszka Krzykwa, Małgorzata Setny, Paweł Kozieł, Marlena Paniczko, Jacek Jamiołkowski, Irina Kowalska, Karol Kamiński. Undiagnosed Diabetes and Prediabetes in Patients with Chronic Coronary Syndromes—An Alarming Public Health Issue. Journal of Clinical Medicine. 2021; 10 (9):1981.

Chicago/Turabian Style

Natalia Drobek; Paweł Sowa; Piotr Jankowski; Maciej Haberka; Zbigniew Gąsior; Dariusz Kosior; Danuta Czarnecka; Andrzej Pająk; Karolina Szostak-Janiak; Agnieszka Krzykwa; Małgorzata Setny; Paweł Kozieł; Marlena Paniczko; Jacek Jamiołkowski; Irina Kowalska; Karol Kamiński. 2021. "Undiagnosed Diabetes and Prediabetes in Patients with Chronic Coronary Syndromes—An Alarming Public Health Issue." Journal of Clinical Medicine 10, no. 9: 1981.

Journal article
Published: 09 April 2021 in Journal of Clinical Medicine
Reads 0
Downloads 0

Background: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among patients in particular cardiovascular risk classes, and to estimate their long term CV risk. Methods: A total of 931 individuals aged 20–79 were included. The study population was divided into CV risk classes according to the latest European Society of Cardiology recommendations. Results: Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants. Interestingly, estimating the lifetime risk of myocardial infarction, stroke or CV death, using the LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes. Conclusion: The participants who belonged to moderate and high CV risk classes had very similar unfavorable cardiometabolic profiles, which may result in similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population, who are often unaware of their situation. New prospective population studies are necessary to establish the true cardiovascular risk profiles in a changing society.

ACS Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Wojciech Łaguna; Paweł Sowa; Marlena Paniczko; Magda Łapińska; Małgorzata Szpakowicz; Natalia Drobek; Andrzej Raczkowski; Karol Kamiński. A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study. Journal of Clinical Medicine 2021, 10, 1584 .

AMA Style

Małgorzata Chlabicz, Jacek Jamiołkowski, Wojciech Łaguna, Paweł Sowa, Marlena Paniczko, Magda Łapińska, Małgorzata Szpakowicz, Natalia Drobek, Andrzej Raczkowski, Karol Kamiński. A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study. Journal of Clinical Medicine. 2021; 10 (8):1584.

Chicago/Turabian Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Wojciech Łaguna; Paweł Sowa; Marlena Paniczko; Magda Łapińska; Małgorzata Szpakowicz; Natalia Drobek; Andrzej Raczkowski; Karol Kamiński. 2021. "A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study." Journal of Clinical Medicine 10, no. 8: 1584.

Journal article
Published: 03 December 2020 in Journal of Clinical Medicine
Reads 0
Downloads 0

Background: Left ventricular diastolic dysfunction (LVDD) is caused by a decreased left ventricle relaxation and is associated with an increased risk of symptomatic heart failure (HF) and excessive mortality. Aim: To evaluate the frequency and factors related to LVDD in the population with chronic coronary syndromes (CCS). Methods: 200 patients (mean age 63.18 ± 8.12 years, 75.5% male) with CCS were included. LVDD was diagnosed based on the recent echocardiography guidelines. Results: LVDD was diagnosed in 38.5% of CCS population. From the studied factors, after adjustment for age, sex, and N-terminal pro-brain natriuretic peptide (NT-proBNP), LVDD associated positively with android/gynoid (A/G) fat mass ratio, left ventricular mass index (LVMI), and negatively with Z-score and left ventricular ejection fraction (LVEF). In stepwise backward logistic regression analysis, the strongest factors associated with LVDD were pulse wave velocity value, handgrip strength and waist to hip ratio (WHR). Conclusions: LVDD is common among CCS patients and it is associated with parameters reflecting android type fat distribution regardless of NT-proBNP and high-sensitivity troponin T concentrations. Deterioration in diastolic dysfunction is linked with increased aortic stiffness independently of age and sex. Further studies evaluating the effects of increasing physical fitness and lowering abdominal fat accumulations on LVDD in CCS patients should be considered.

ACS Style

Marlena Paniczko; Małgorzata Chlabicz; Jacek Jamiołkowski; Paweł Sowa; Małgorzata Szpakowicz; Magda Łapińska; Marcin Kondraciuk; Katarzyna Ptaszyńska-Kopczyńska; Andrzej Raczkowski; Anna Szpakowicz; Karol Adam Kamiński. Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes. Journal of Clinical Medicine 2020, 9, 3924 .

AMA Style

Marlena Paniczko, Małgorzata Chlabicz, Jacek Jamiołkowski, Paweł Sowa, Małgorzata Szpakowicz, Magda Łapińska, Marcin Kondraciuk, Katarzyna Ptaszyńska-Kopczyńska, Andrzej Raczkowski, Anna Szpakowicz, Karol Adam Kamiński. Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes. Journal of Clinical Medicine. 2020; 9 (12):3924.

Chicago/Turabian Style

Marlena Paniczko; Małgorzata Chlabicz; Jacek Jamiołkowski; Paweł Sowa; Małgorzata Szpakowicz; Magda Łapińska; Marcin Kondraciuk; Katarzyna Ptaszyńska-Kopczyńska; Andrzej Raczkowski; Anna Szpakowicz; Karol Adam Kamiński. 2020. "Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes." Journal of Clinical Medicine 9, no. 12: 3924.

Journal article
Published: 06 May 2020 in Journal of Clinical Medicine
Reads 0
Downloads 0

Background: Left ventricular hypertrophy (LVH) is an important risk factor for cardiovascular events. The electrocardiography (ECG) has poor sensitivity, but it is commonly used to detect LVH. Aim: To evaluate the diagnostic efficacy of known ECG indicators to recognize LVH in subgroups with different cardiovascular risk levels. Methods: 676 volunteers were included. Results: We found that 10.2% of the analyzed population had LVH based on echocardiography. Individuals with LVH were older, had a higher body mass index, higher systolic blood pressure, lower heart rate, higher parameters of insulin resistance, higher cardiovascular risk, and android-type obesity. Variables that remained independently associated with LVH were QRS duration, left atrial volume index, troponin T, and hemoglobin A1c. The receiver operating characteristics (ROC) curve analysis of the Sokolow–Lyon index did not show a significant predictive ability to diagnose LVH in the whole study population including all cardiovascular risk classes. The ROC curves analysis of Cornell and Lewis indices showed a modest predictive ability to diagnose LVH in the general population and in a low cardiovascular class. Conclusions: There is a need for new, simple methods to diagnose LVH in the general population in order to properly evaluate cardiovascular risk and introduce optimal medical treatment of concomitant disease.

ACS Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Marlena Paniczko; Paweł Sowa; Małgorzata Szpakowicz; Magda Łapińska; Natalia Jurczuk; Marcin Kondraciuk; Katarzyna Ptaszyńska-Kopczyńska; Andrzej Raczkowski; Anna Szpakowicz; Karol Adam Kamiński. ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk. Journal of Clinical Medicine 2020, 9, 1364 .

AMA Style

Małgorzata Chlabicz, Jacek Jamiołkowski, Marlena Paniczko, Paweł Sowa, Małgorzata Szpakowicz, Magda Łapińska, Natalia Jurczuk, Marcin Kondraciuk, Katarzyna Ptaszyńska-Kopczyńska, Andrzej Raczkowski, Anna Szpakowicz, Karol Adam Kamiński. ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk. Journal of Clinical Medicine. 2020; 9 (5):1364.

Chicago/Turabian Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Marlena Paniczko; Paweł Sowa; Małgorzata Szpakowicz; Magda Łapińska; Natalia Jurczuk; Marcin Kondraciuk; Katarzyna Ptaszyńska-Kopczyńska; Andrzej Raczkowski; Anna Szpakowicz; Karol Adam Kamiński. 2020. "ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk." Journal of Clinical Medicine 9, no. 5: 1364.

Journal article
Published: 27 December 2019 in Journal of Clinical Medicine
Reads 0
Downloads 0

Background: Natriuretic peptides (NPs), including brain natriuretic peptide (BNP), are neurohormones involved in the regulation of water-sodium balance and the maintenance of cardiovascular homeostasis. A higher concentration of NPs is observed in females, but the mechanism behind this difference has not been fully elucidated. Methods: Randomly chosen 255 volunteers from the general population were examined. Overall, 196 people without severe cardiovascular disease were included (mean age 48 years, 35.7% male). A comprehensive assessment was performed, including anthropometric measurements, N-terminal pro-brain natriuretic peptide (NT-proBNP), total testosterone (TT) and sex hormone-binding globulin (SHBG) concentration, transthoracic echocardiography (ECHO), and body composition analysis by direct dual-energy X-ray absorptiometry (DEXA). The univariate analysis adjusted by the known affecting factors determined which measurements were independently associated with NT-proBNP concentration. Results: NT-proBNP concentration was positively associated with gynoid fat mass, gynoid/total fat (G/TF) mass index, SHBG and negatively with android/gynoid (A/G) fat mass index, TT and calculated free testosterone (CFT) concentrations. Furthermore, body composition parameters remained independently associated with NT-proBNP levels even after adjusting for CFT and SHBG. Conclusion: In the population without severe cardiovascular disease, the NT-proBNP concentration is independently associated with lower availability of testosterone and higher gynoid fat distribution, which may explain higher NPs levels in females.

ACS Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Marlena Paniczko; Paweł Sowa; Magda Łapińska; Małgorzata Szpakowicz; Natalia Jurczuk; Marcin Kondraciuk; Andrzej Raczkowski; Emilia Sawicka; Karol Adam Kamiński. Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans. Journal of Clinical Medicine 2019, 9, 74 .

AMA Style

Małgorzata Chlabicz, Jacek Jamiołkowski, Marlena Paniczko, Paweł Sowa, Magda Łapińska, Małgorzata Szpakowicz, Natalia Jurczuk, Marcin Kondraciuk, Andrzej Raczkowski, Emilia Sawicka, Karol Adam Kamiński. Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans. Journal of Clinical Medicine. 2019; 9 (1):74.

Chicago/Turabian Style

Małgorzata Chlabicz; Jacek Jamiołkowski; Marlena Paniczko; Paweł Sowa; Magda Łapińska; Małgorzata Szpakowicz; Natalia Jurczuk; Marcin Kondraciuk; Andrzej Raczkowski; Emilia Sawicka; Karol Adam Kamiński. 2019. "Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans." Journal of Clinical Medicine 9, no. 1: 74.